SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001359824-17-000013
Filing Date
2017-02-13
Accepted
2017-02-13 16:38:51
Documents
1

Document Format Files

Seq Description Document Type Size
1 trillium13ga.htm SC 13G/A 103882
  Complete submission text file 0001359824-17-000013.txt   105135
Mailing Address THE MOTTOLA COMPANY, 156 WEST 56TH ST 4TH FLOOR NEW YORK NY 10019
Business Address
Mottola Thomas D (Filed by) CIK: 0001561243 (see all company filings)

Type: SC 13G/A

Mailing Address 2488 DUNWIN DRIVE MISSISSAUGA A6 L5L 1J9
Business Address 2488 DUNWIN DRIVE MISSISSAUGA A6 L5L 1J9 (416) 595-0627
Trillium Therapeutics Inc. (Subject) CIK: 0001616212 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1214
Type: SC 13G/A | Act: 34 | File No.: 005-88719 | Film No.: 17599840
SIC: 2834 Pharmaceutical Preparations